Reviva Pharmaceuticals Holdings Inc (RVPH)
1.125
-0.08
(-7.02%)
USD |
NASDAQ |
Nov 15, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Net Income (Quarterly): -7.860M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -7.860M |
| March 31, 2024 | -7.434M |
| December 31, 2023 | -9.724M |
| September 30, 2023 | -10.49M |
| June 30, 2023 | -11.71M |
| March 31, 2023 | -6.852M |
| December 31, 2022 | -12.04M |
| September 30, 2022 | -3.515M |
| June 30, 2022 | -5.341M |
| March 31, 2022 | -7.365M |
| Date | Value |
|---|---|
| December 31, 2021 | -3.685M |
| September 30, 2021 | -2.279M |
| June 30, 2021 | -1.608M |
| March 31, 2021 | -0.9493M |
| December 31, 2020 | -1.524M |
| November 30, 2020 | -0.3482M |
| September 30, 2020 | -0.6591M |
| June 30, 2020 | -0.8514M |
| March 31, 2020 | -0.749M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-12.04M
Minimum
Dec 2022
-0.3482M
Maximum
Nov 2020
-4.999M
Average
-3.685M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| Eyenovia Inc | -11.05M |
| NovaBay Pharmaceuticals Inc | -1.212M |
| Palatin Technologies Inc | -8.250M |
| iBio Inc | -7.778M |
| Theriva Biologics Inc | -8.316M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 8.130M |
| EPS Diluted (Quarterly) | -0.26 |
| Enterprise Value | 31.26M |
| Earnings Yield | -115.6% |